Tenders Are Invited For Pharmaceutical Products - Open House Pharmaceutical Discounts In Accordance With Section 130A (8C) Sgb V Bevacizumab, Atc L01fg01

Pharmaceutical Products - Open House Pharmaceutical Discounts In Accordance With Section 130A (8C) Sgb V Bevacizumab, Atc L01fg01. It Is Not An Open Procedure, But A So-Called Open-House Model! The Form For The Open Procedure Is Only Used Because There Is No Form For The Open House Model. Contracts That Are Concluded In The Open House Model Are Not Subject To Procurement Law Due To A Lack Of Selection Decision. A Submission Under Public Procurement Regulations Is Not Connected To The Use Of This Form. The Aok Bayern - The Health Insurance Fund, Acting As A State Association (Section 207 (4) Sgb V), The Bkk Landesverband Bavaria, The Ikk Classic Acting As A State Association (§ 207 Paragraph 4A Sgb V), Consisting Of The Guild Health Insurance Companies: Ikk Classic, Ikk - The Innovation Cash, Ikk Südwest, Big Directly Healthy, Ikk, Ikk, Ikk Brandenburg And Berlin, Ikk Gesund Plus, Social Insurance For Agriculture, Forestry And Horticulture (Svlfg) As An Agricultural Health Insurance Company, Acting As A State Association (§ 36 Kvlg 1989) The Knappschaft, The Techniker Krankenkasse (Tk), The Barmer Health, The Commercial Health Insurance - Kkh, The Hek - Hanseatic Health Insurance Company (Hkk) Intend To Conclude Non-Exclusive Discount Agreements On The Active Ingredient Bevacizumab, Atc L01fg01, According To § 130A Paragraph 8C Sgb V For Parenteral Preparations Made From Ready-Made Medicine In Oncology For Direct Medical Use In Patients For The Bavaria Region. The Aok Bayern Is Authorized To Conclude These Discount Agreements, The Termination Of Which Necessary And Other Actions Necessary As Part Of The Open House Procedure. The Clients Offer All Interested Pharmaceutical Companies That Meet The Equivalent Requirements Below, The Conclusion Of Identical And Not Individually Negotiable Discount Agreements. The Earliest Possible Contract Is 01.07.2025, All Contracts End On June 30, 2027. A Contract Is Concluded During This Term At Any Time, But At The Latest On April 16, 2027. The Contracts Can Be Terminated With A Period Of Eight Weeks At The End Of The Month. When The Discount Contract For The Region Of Bavaria, Which Is Concluded Through Nationwide Or Country-Specific Discount Contract With The Order-Related Active Ingredient For The Order Of The Order For The Region, Is Automatically Overridden For The Corresponding Term. A Contract Is Concluded With All Interested Pharmaceutical Companies That Demonstrate Their Suitability Through A Completed And Signed Self -Declaration For Reliability. The Pharmaceutical Entrepreneur Has The Completed And Signed (The Signatory Authorization Of The Signatories/S Must Result From The Extracts From The Commercial Register, Otherwise A Power Of Attorney Must Be Submitted) Contract With A Completed File Ohv_8C_Bayern_Pfestlung_Pzn As Well As The Filled And Signed E